Follow us on:

Purchase Report

Purchasing Item: 2015 Cash Rich/Debt Free, Profitable Canadian Micro to Mid-Cap Report
  Starting with over 3,500 Canadian stocks, our research uncovers over 60 Small to-Micro Cap stocks – all profitable, cash rich (no debt) companies, many with between 10-100% of their market caps in cash. We drill down on each providing fundamental statistics and research notes from our management interviews and provide a select number of NEW BUY Reports. Flash Updates with current BUYS|SELL|HOLD ratings on all Cash Rich Stocks currently in coverage. New buy recommendations include 2 high growth software Small-Caps, one low-priced Micro-Cap and bonus notes on our recent Specialty Pharmaceutical selection which trades at a significant discount to its peers. The report has become an annual must read for growth and value investors and with 16 stocks receiving premium takeover bids it serves as an excellent source of potential takeover targets.Unique research you can find nowhere else. Last year’s Top Cash Rich recommendation Cipher Pharmaceuticals (CPH:TSX), has gained over 155% - do not miss out on this year’s recommendations.
Cost: $0.00

You must have a client account and be logged in to add this item to your purchased reports. If you already have an account, please login now. If you do not have an account, registration is free.

Please Note:

This purchase is a one-time, non-recurring transaction entitling the purchaser to personal use of the report listed above and that report only.
Prices are listed in Canadian dollars unless otherwise noted. Canadian residents: Applicable sales tax (HST or GST) will be added to your purchase. U.S. and international residents: GST does not apply. Email-based subscribers receive an emailed version and access to the online-content for the duration of their subscriptions. Hard copies are typically received 8-10 business days after the publishing date due to printing and mailing time.